netFormulary NHS
Coastal West Sussex
Local Health Economy Formulary

Welcome to the Coastal West Sussex Local Health Economy Formulary

If the product you search for is not found, it is currently non-formulary, and should not be routinely prescribed.

Useful Links

Effective Shared Care Agreements (ESCAs) Adult nutrition guidance South Central Antimicrobial Network
Area Prescribing Committee (APC) CWS formulary application forms NICE Technology appraisals adherence checklist
Patient Resources Keeping Tabs Newsletter Infant Feeding Guidelines
Specials Guidance

Policies, Guidelines and Pathways

CWS CCG Website
Continence Formulary Dressings Formulary Blue Coding – Information sheets
Quality Improvement Scheme (QIS) National Reporting and Learning System (NRLS) Sussex Partnership NHS Foundation Trust (SPfT) link
Medicines Supply Updates Medicines Safety Information Sussex Community NHS Foundation Trust (SCfT) link
Individual Funding Requests Self Care Prescribing Guidance
  Download net formulary from Apple IOS Store Google Play net formulary


News Feed

November 2019 - Managing females of child bearing potential (FCBP) prescribed valproate at the primary/secondary care interface:

  • A primary/secondary care interface document for managing females of child bearing potential (FCBP) prescribed valproate is now available here. It includes a form for patients to complete and sign to acknowledge the potential risks if they are unwilling to engage in the annual review process, but request that their sodium valproate continues to be prescribed.

October 2019 – Denosumab (Prolia®) injections:

  • For patients being initiated on denosumab (Prolia®) injections, WSHfT have always administered at least the first two injections before transferring prescribing/administration responsibility to primary care. It was agreed by the Area Prescribing Committee that this be amended to at least the first injection, to free up clinical time for the osteoporosis nurses to see more new patients and undertake more DEXA scan reporting.

September 2019 - Updated melatonin prescribing guidance:

  • A recent situation regarding a new melatonin product (licensed only for jet lag in adults) has caused confusion and disruption between patients, prescribers and pharmacies. CWS CCG has issued a letter providing clarification and guidance for all CWS prescribers, which is available here.

August 2019 - Availability of Emerade 0.3mg and Emerade 0.5mg Adrenaline Auto-Injectors:

Emerade (adrenaline auto-injector devices) will be subject to short term disruption to supply.  The manufacturer (Bausch & Lomb) states:

  • Emerade 500 microgram is out of stock until the 28 August 2019.
  • Emerade 300 microgram has limited supplies remaining but will be out of stock from early-mid August with further supplies expected by 30 September 2019.

Supply disruption alert from the Department of Health and Social Care

MHRA Adrenaline auto-injectors: updated advice after European review

If an alternative brand is prescribed,  the patient or carer will need to be trained on how to administer the new auto-injector.

June 2019 - Revised continence formulary:

May 2019 - Revised CWS Position Statement regarding Freestyle Libre®:

>>> more news


The Coastal West Sussex local health economy formulary is the output of processes to support the managed introduction, utilisation or withdrawal of healthcare treatments in Coastal West Sussex. It is managed through the Coastal West Sussex Area Prescribing Committee and applies to all prescribers across the local health economy including Coastal West Sussex Clinical Commissioning Group, Western Sussex Hospitals NHS Foundation Trust, Sussex Partnership NHS Foundation Trust and Sussex Community NHS Trust.

The formulary is now up to date with respect to all the traffic light document information as well as the following currently ratified full BNF therapeutic chapters:

-Musculoskeletal and joint diseases
-Low Molecular Weight Heparins
-Ear, nose, and oropharynx

The following sections have been ratified by CWS APC but are only available as standalone documents under the useful links (supporting formulary documents) currently:

-Oral Nutrional Supplements

All NICE positively appraised medicines are automatically included within the formulary (where clinically appropriate) and these can be accessed via the NICE technology appraisal adherence checklist link above. These medicines are available for clinicians to prescribe, should they choose to, in a way that supports safe and clinically appropriate practice. Prescribing responsibility is defined within the traffic light system.

The technology in a NICE technology appraisal may not be the only treatment for a particular condition. If a NICE technology appraisal recommends use of a technology, it is as an option for the treatment of a disease or condition. This means that the technology should be available for a patient who meets the clinical criteria set out in the guidance, subject to the clinical judgement of the treating clinician. The NHS must provide funding and resources when the clinician concludes and the patient agrees that the recommended technology is the most appropriate to use, based on a discussion of all available treatments

The Medicines Management team are always happy to receive any feedback on the formulary. Please use the feedback button at the top of the page if you wish to contact us in relation to the formulary.

Every care has been taken in the compilation and publication of the content on our website. However, Coastal West Sussex Area Prescribing Committee (and its consituent NHS members) will not be held responsible for any loss, damage or inconvenience caused as a result of any inaccuracy or error within these pages.

Please note that all material in this site is aimed at healthcare professionals. Members of the public seeking advice on any medicine-related matters are encouraged to contact NHS 111 or speak with their GP, pharmacist or nurse.

Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement. Links to NHS member organisational policies or guidelines may not be accessible from all locations

We cannot accept any responsibility for any loss, disruption or damage to your data or your computer system that may occur while using material derived from this website.

   Visits = 457282
   Last updated: 15/01/2020 17:53:15
    Download net formulary from Apple IOS Store  Google Play net formulary